Ciproxin licensed for UTI in children

The licence for Ciproxin (ciprofloxacin) has been extended to include the second- and third-line treatment of complicated UTIs and pyelonephritis in children and adolescents aged between 1-17 years.

The dose is 10-20mg/kg orally every 12 hours up to a maximum of 750mg per dose. The recommended duration of treatment is 10-21 days.

View Ciproxin drug record

Further information: Bayer plc

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Omega-3 supplements withdrawn from secondary prevention use

Omega-3 supplements withdrawn from secondary prevention use

Omega-3 fatty acids can no longer be prescribed to...

MIMS supplement on contraception and HRT

MIMS supplement on contraception and HRT

The December issue of MIMS includes a special supplement...

Drug shortages - live tracker

Drug shortages - live tracker

Added: clonidine.
Use our constantly updated shortages...

Prescribers reassured over metformin contamination

Prescribers reassured over metformin contamination

Trace amounts of the potential carcinogen N-nitrosodimethylamine...